Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
01 Fevereiro 2024 - 6:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that
company management will present at the Guggenheim 6th Annual
Biotechnology Conference on Thursday, February 8, 2024, at 11:30
a.m. ET.
A live webcast will be accessible on the Investor page of
Travere’s website at ir.travere.com/events-presentations, and a
replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families, and caregivers of all backgrounds
as they navigate life with a rare disease. On this path, we know
the need for treatment options is urgent – that is why our global
team works with the rare disease community to identify, develop,
and deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Contact:
Investors:888-969-7879 ir@travere.com |
Media:888-969-7879 mediarelations@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024